1392208-04-6
1392208-04-6
Chemical Structure
(Rac)-Ropivacaine-d7
- CAS No.: 1392208-04-6
- Formula:C17H19D7N2O
- Molecular Weight:281.44
IUPAC Name: N-(2,6-dimethylphenyl)-1-(propyl-d7)piperidine-2-carboxamide
InChIKey: ZKMNUMMKYBVTFN-JNIQENOFSA-N
SMILES: CC(C=CC=C1C)=C1NC(C2N(CCCC2)C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=O
Biological Activity: (Rac)-Ropivacaine-d7 is the deuterium labeled (Rac)-Ropivacaine[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(Rac)-Ropivacaine-d7 | (Rac)-Ropivacaine-d7 is the deuterium labeled (Rac)-Ropivacaine. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ropivacaine (Standard) | ≥98% | Ropivacaine (Standard) is the analytical standard of Ropivacaine. This product is intended for research and analytical applications. Ropivacain is a potent sodium channel blocker. Ropivacain blocks impulse conduction via reversible inhibition of sodium ion influx in nerve fibrese. Ropivacaine is also an inhibitor of K2P (two-pore domain potassium channel) TREK-1 with an IC50 of 402.7 μM in COS-7 cell's membrane. Ropivacaine is used for the research of neuropathic pain management. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ropivacaine-d7 | 99.69% | Ropivacaine-d7 is deuterium labeled Ropivacaine. Ropivacain is a potent?sodium channel?blocker. Ropivacain blocks impulse conduction via reversible inhibition of?sodium ion influx?in nerve fibrese. Ropivacaine is also an inhibitor of K2P (two-pore domain potassium channel) TREK-1 with an IC50 of 402.7 μM in COS-7 cell's membrane. Ropivacaine is used for the research of neuropathic pain?management. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ropivacaine-d7 hydrochloride | Ropivacaine-d7 hydrochloride is a deuterium labeled Ropivacaine (hydrochloride) (HY-B0563B). Ropivacaine hydrochloride is a potent sodium channel blocker and blocks impulse conduction via reversible inhibition of sodium ion influx in nerve fibrese. Ropivacaine is also an inhibitor of K2P (two-pore domain potassium channel) TREK-1 with an IC50 of 402.7 μM in COS-7 cell's membrane. Ropivacaine is widely used for neuropathic pain management in vivo. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ropivacaine | 99.98% | Ropivacain is a potent sodium channel blocker. Ropivacain blocks impulse conduction via reversible inhibition of sodium ion influx in nerve fibrese. Ropivacaine is also an inhibitor of K2P (two-pore domain potassium channel) TREK-1 with an IC50 of 402.7 μM in COS-7 cell's membrane. Ropivacaine is used for the research of neuropathic pain management. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
